All videos

The shingles vaccine could protect against dementia

This video is part of: Centre for Health and Healthcare

People who took a shingles vaccine were 20% less likely to develop dementia, scientists found. It’s the strongest evidence yet for the unexpected side effect of the shingles vaccine. Scientists studied a vaccine called Zostavax, which was rolled out in Wales in 2013. It was only available to people born on or after 2 September 1933. So a team at Stanford University compared patients born in the week before the cut-off with those born the week after. Over the next 7 years, dementia diagnoses fell by 3.5 percentage points in the cohort who took the shot which equated to a 20% relative reduction.

Topics:
Health and Healthcare Systems
Share:
World Economic Forum logo

Forum Stories newsletter

Bringing you weekly curated insights and analysis on the global issues that matter.

Subscribe today

More on Health and Healthcare Systems
See all

Resilient health: a new investment frontier

December 22, 2025

Quantum vs AI in healthcare: How they differ and why leaders must prepare for convergence

2:11

About us

Engage with us

Quick links

Language editions

Privacy Policy & Terms of Service

Sitemap

© 2025 World Economic Forum